Reviewing OptiNose (OPTN) and Editas Medicine (NASDAQ:EDIT)TrueBlueTribuneIt is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribonucleic acid (RNA) c… Continue reading
CRISPR technology needs smart oversight, not heavy regulationCedar County RepublicanIn one of the final actions of the outgoing Obama administration, the FDA announced they would regulate CRISPR technology as a drug. CRISPR edits DNA, not adding genes … Continue reading
|
3 Reasons Celgene’s Investors Should Applaud the Juno Therapeutics Buyout
Motley Fool Specifically, the company is working on an exciting new type of treatment called chimeric antigen receptor T–cell therapy, or CAR-T. This therapy extracts a patient’s T–cells and then reprograms them to be able to identify cancer. Once complete, they … |
CNN |
Running the ‘Doomsday Clock’ is a full-time job. Really.
CNN Emerging technology hasn’t caused the clock to move … yet. But the Bulletin keeps its eye on synthetic biology, artificial intelligence and cyberhacking to assess their threat level to humanity. The last time the clock was as close to midnight as it … |
|
Researcher using gene therapy to battle hearing loss
The Boston Globe It’s hard to make a chicken deaf. Sounds like a joke, but by sound-blasting chickens and looking at their inner ears, researchers found that chickens can regrow hair cells crucial for hearing. If this same cell regeneration could be replicated in … |